"Elekta is committed to increase access to radiotherapy in underserved markets and through the SLB Framework we link our funding with the target that supports our most material sustainability ambitions and that is fully aligned with our vision - a world where everyone has access to the best cancer care. To increase availability of cancer care is one dimension in reaching Elekta's vision, the other two dimensions are elevation of care and participation in care," says
Elekta has a unique opportunity to provide hope for everyone dealing with cancer in all corners of the world. Today, low- and middle-income countries bear a larger burden of cancer mortality than high-income countries.1 By selecting increased access to radiotherapy in these underserved markets as Key Performance Indicator (KPI), Elekta is positively contributing to sustainable development. Elekta commits to increase the installed net base of linacs in underserved markets with 825 units by
"The rationale and process for Elekta's KPI selection, as well as its definition, measurability, and verifiability, are deemed to be robust, reliable and in accordance with the
Elekta will issue bonds based on the SLB Framework and has updated its MTN-Program base prospectus, originally published in 2015. The prospectus has been approved by the
1Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16-27.
# # #
For further information, please contact:
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET (Central European Time)
Tel: +46 72 966 26 47, e-mail: bujar.bunjaku@elekta.com
Time zone: CET (Central European Time)
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in
https://news.cision.com/elekta/r/elekta-establishes-a-framework-for-sustainability-linked-bonds,c3442936
https://mb.cision.com/Main/35/3442936/1488218.pdf
(c) 2021 Cision. All rights reserved., source